Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by TD Securities and TD Cowen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TD Securities and TD Cowen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Drugging The Undruggable: CEO Mike Cloonan's Journey To Sionna Therapeutics

14:27
 
Share
 

Manage episode 474777695 series 3276203
Content provided by TD Securities and TD Cowen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TD Securities and TD Cowen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Recorded on 03/03/25

TD Cowen senior biotech analyst Ritu Baral speaks with SION's CEO Mike Cloonan at TD Cowen's 45th Annual Health Care Conference to discuss his journey becoming a start-up biotech CEO and leading SION through a successful IPO in turbulent markets. Cloonan's path to CEO started with early career roles and skill development throughout all functions of a company – commercial, R&D, and SG&A. Joining Sionna with prior experience at large and mid-cap companies, Cloonan emphasizes how his nimbleness and ability to prioritize goals has helped him successfully lead a small start-up through a smooth IPO. Cloonan discusses SION's ability to "drug the undruggable" through targeting NBD1 as a main reason he decided to lead SION, while also highlighting the importance of leading with intention to identify the unmet need of patients.

https://go.td.com/PodcastDisclosure

  continue reading

278 episodes

Artwork
iconShare
 
Manage episode 474777695 series 3276203
Content provided by TD Securities and TD Cowen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TD Securities and TD Cowen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Recorded on 03/03/25

TD Cowen senior biotech analyst Ritu Baral speaks with SION's CEO Mike Cloonan at TD Cowen's 45th Annual Health Care Conference to discuss his journey becoming a start-up biotech CEO and leading SION through a successful IPO in turbulent markets. Cloonan's path to CEO started with early career roles and skill development throughout all functions of a company – commercial, R&D, and SG&A. Joining Sionna with prior experience at large and mid-cap companies, Cloonan emphasizes how his nimbleness and ability to prioritize goals has helped him successfully lead a small start-up through a smooth IPO. Cloonan discusses SION's ability to "drug the undruggable" through targeting NBD1 as a main reason he decided to lead SION, while also highlighting the importance of leading with intention to identify the unmet need of patients.

https://go.td.com/PodcastDisclosure

  continue reading

278 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play